Cargando…
Metastatic disease from uveal melanoma: treatment options and future prospects
Uveal melanoma represents ∼85% of all ocular melanomas and up to 50% of patients develop metastatic disease. Metastases are most frequently localised to the liver and, as few patients are candidates for potentially curative surgery, this is associated with a poor prognosis. There is currently little...
Autores principales: | Carvajal, Richard D, Schwartz, Gary K, Tezel, Tongalp, Marr, Brian, Francis, Jasmine H, Nathan, Paul D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256122/ https://www.ncbi.nlm.nih.gov/pubmed/27574175 http://dx.doi.org/10.1136/bjophthalmol-2016-309034 |
Ejemplares similares
-
Treatment of uveal melanoma: where are we now?
por: Yang, Jessica, et al.
Publicado: (2018) -
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
por: Krantz, Benjamin A, et al.
Publicado: (2017) -
Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
por: Wei, Alexander Z., et al.
Publicado: (2022) -
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
por: Damato, Bertil E., et al.
Publicado: (2019) -
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)